Recently, the correlation between the baseline IL-6 and CRP in melanoma treated with immune checkpoint inhibitors (ICIs) or chemotherapy was demonstrated, and higher levels of IL-6 were significantly associated with poor survival37. The gene discussed is IL6; the disease is melanoma.